EUVIMEDSkopri EUVIMED
Multizentrische StudieOpen access · CC BY-NC-ND 4.0

Serum proteome profiles in cats with chronic enteropathies

Jane Yu iD, Lara Boland, Melissa Catt, Leah Puk, Nadia Wong, Mark Krockenberger, Peter Bennett iD, Craig Ruaux iD, Valerie C Wasinger

Journal of Veterinary Internal Medicine · 2023

DOI: 10.1111/jvim.16743 ↗

At a glance

Multizentrische Studie in Journal of Veterinary Internal Medicine, 2023. Written by Jane Yu and 8 co-authors. Institution: Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Sydney, New South Wales, 2006, Australia. Major MEDLINE topics: Inflammatory Bowel Diseases, Cat Diseases. Cited 9 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Betty & Keith Cook Canine Research Fund.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Serum protein biomarkers are used to diagnose, monitor treatment response, and to differentiate various forms of chronic enteropathies (CE) in humans. The utility of liquid biopsy proteomic approaches has not been examined in cats. Hypothesis/Objectives To explore the serum proteome in cats to identify markers differentiating healthy cats from cats with CE. Animals Ten cats with CE with signs of gastrointestinal disease of at least 3 weeks duration, and biopsy-confirmed diagnoses, with or without treatment and 19 healthy cats were included.

Methods

Cross-sectional, multicenter, exploratory study with cases recruited from 3 veterinary hospitals between May 2019 and November 2020. Serum samples were analyzed and evaluated using mass spectrometry-based proteomic techniques.

Results

Twenty-six proteins were significantly (P < .02, ≥5-fold change in abundance) differentially expressed between cats with CE and controls. Thrombospondin-1 (THBS1) was identified with >50-fold increase in abundance in cats with CE (P < 0.001) compared to healthy cats. Conclusions and Clinical Importance Damage to the gut lining released marker proteins of chronic inflammation that were detectable in serum samples of cats. This early-stage exploratory study strongly supports THBS1 as a candidate biomarker for chronic inflammatory enteropathy in cats.

Subjects

MeSH terms (MEDLINE)

Inflammatory Bowel DiseasesCat DiseasesHumansCatsAnimalsProteomeProteomicsCross-Sectional StudiesBiomarkers

Author keywords

alimentary small cell lymphomabiomarkerschronic enteropathieslow-grade alimentary lymphomaproteinsproteomics

Substances

ProteomeBiomarkers

Authors and institutions

  • Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Sydney, New South Wales, 2006, Australia.
  • Paddington Cat Hospital, Paddington, New South Wales, Australia.
  • McIvor Road Veterinary Centre, Bendigo, Victoria, Australia.
  • Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, New South Wales, Australia.

ORCID profiles: Jane Yu, Peter Bennett, Craig Ruaux

Funding

  • Betty & Keith Cook Canine Research Fund

Cite

APA

Yu, J., Boland, L., Catt, M., Puk, L., Wong, N., Krockenberger, M., Bennett, P., Ruaux, C., & Wasinger, V. C. (2023). Serum proteome profiles in cats with chronic enteropathies. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16743

Vancouver

Yu J, Boland L, Catt M, Puk L, Wong N, Krockenberger M, et al. Serum proteome profiles in cats with chronic enteropathies. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16743

BibTeX
@article{Yu2023,
  author = {Yu, Jane and Boland, Lara and Catt, Melissa and Puk, Leah and Wong, Nadia and Krockenberger, Mark and Bennett, Peter and Ruaux, Craig and Wasinger, Valerie C},
  title = {Serum proteome profiles in cats with chronic enteropathies},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2023},
  doi = {10.1111/jvim.16743}
}
Start for free →